Eli Lilly and Company
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| LLYCL.SN | BIIB | BMY | AZN | NVO | PFE | |
|---|---|---|---|---|---|---|
| Market cap | 1,016.15T | 34.37B | 122.05B | 256.54B | 171.36B | 168.60B |
| P/E (TTM) | 41.5 | 41.3 | 13.2 | 23.8 | 9.5 | 38.9 |
| Forward P/E | — | 14.1 | 9.0 | 14.6 | 11.4 | 10.2 |
| Price/book | 29,998.4 | 1.8 | 5.5 | 5.1 | 5.2 | 2.0 |
| Dividend yield | 0.58% | — | 4.22% | 1.94% | 4.63% | 5.81% |
| 1-year change | +44.27% | +58.66% | +37.07% | −1.39% | −30.34% | +19.81% |
| Today | −0.36% | −1.15% | −1.35% | −0.76% | −0.99% | +0.48% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 20 min.
Latest news
All LLYCL.SN news ›These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; Eli Lilly Leads Industry
Investor's Business Daily BREAKING: Meta, SpaceX Earnings Loom After S&P 500, Nasdaq Break Support As the stock market tries to get its footing, it's important to watch the stocks that are holding up and are most loved by equity analysts.…
Pennsylvania sues Eli Lilly, CVS Caremark, and others, alleging insulin prices were inflated 1,000%
The case could bring direct financial recovery and add pressure on the companies named in the suit. A new Pennsylvania lawsuit targets major insulin manufacturers and pharmacy benefit managers, accusing them of working in concert to…
NIH-Funded Study Finds GLP-1 Drugs Slow Aging In Mice, Boosting Outlook For Novo Nordisk (NYSE: NVO) And Eli Lilly (NYSE: LLY)
By Ewan Scott | Oct 18, 2026 | Economy & Business, Featured, News & Analysis A government-funded study has found that the GLP-1 drug semaglutide extended lifespan in older, healthy mice by tempering the detrimental effects of aging. The…
Market Expectation Breaker; Apple, Eli Lilly, Cheesecake Factory In Focus - Video - IBD
Oct 16, 2026|05:51 PM ET|ED CARSON, MIKE WEBSTER Ed Carson and Mike Webster walk through Friday's market action with a discussion of key stocks to watch in Stock Market Today. Market Expectation Breaker; Apple, Eli Lilly, Cheesecake…
A $1,000 Investment in Eli Lilly Became $18,637. The Obesity Boom Changed Everything
Eli Lilly spent most of its 150-year history as a quiet insulin maker before a single drug reshuffled the entire obesity market and turned a modest stake into a fortune that left the S&P 500 in the dust. The question… Ten years ago, Eli…
The EU’s Drug Regulator Backed Eli Lilly’s Weight-Loss Pill. Here’s What Foundayo Has to Show on October 29
Eli Lilly and Company (LLY) moved a step closer to selling its Foundayo weight-loss pill in the European Union on October 16. That day, the European Medicines Agency announced that its human medicines committee recommends approval. The…
Novo Nordisk and Eli Lilly Just Got Some Fantastic News
If the market for GLP-1 drugs wasn't already expanding rapidly enough, makers of these miracle drugs just got news that could accelerate its growth. A study conducted on mice and funded by the National Institutes of Health (NIH) has shown…
What Was Eli Lilly Telling You Before Its Stock Ran?
An investor who put $10,000 into Eli Lilly (LLY) stock on October 14, 2025 held about $15,500 by October 15, 2026. Placing that same sum in the S&P 500 over the identical period would have yielded about $11,790. By mid-2026, two drugs,…
Eli Lilly (LLY) to Present New Oncology Data at ESMO Congress in Madrid
For more on GF Value™, visit GuruFocus GF Value™ for LLY. The GF Score™ is a comprehensive gauge of a company’s overall financial health and quality, integrating factors such as profitability, growth, financial strength, valuation, and…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
marketscreener.com24
-
fool.com23
-
theglobeandmail.com18
-
gurufocus.com15
-
seekingalpha.com15
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.